The role of recombinant interleukin-2 in therapy for hematologic malignancies. [electronic resource]
- Seminars in oncology Dec 1993
- 33-40 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
0093-7754
Clinical Trials as Topic Diphtheria Toxin--therapeutic use Hematologic Diseases--immunology Humans Interleukin-2--therapeutic use Leukemia--immunology Lymphoma--immunology Receptors, Interleukin-2--physiology Recombinant Fusion Proteins Recombinant Proteins--therapeutic use